Skip to content
Dose Brief
Menu
No. 225 here · Grade C

Tell Her Doc review

Tell Her Doc is a women-focused, self-pay telehealth program for compounded GLP-1 weight loss — compounded semaglutide and tirzepatide in injection, oral, and orally-dissolving-tablet forms, plus microdoses.

Visit Tell Her Doc Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
From $269/mo (microdose tier, plus a separate fee, compounded)
Tirzepatide
Not disclosed
Coverage
All 50 states
Brand-name
Compounded only

Prices read from Tell Her Doc's own site on . Providers change pricing without notice — check the current figure before you buy.

On the trackerNewnew to the tracker, no prior reading— New to the tracker on 1 August 2026. The published line reads From $269/mo (microdose tier, plus a separate fee, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

The scorecard

Tell Her Doc scored on our six Brief Score factors. See the methodology.

Price Stability34/100
Supply Reliability71/100
Transparency80/100
Access Breadth86/100
Clinical Oversight76/100
Track Record65/100

What we like

  • Full compounded GLP-1 lineup — semaglutide and tirzepatide in injection, oral and orally-dissolving-tablet forms, plus microdoses
  • Names its compounding pharmacy partner (Casa Pharma RX), which is independently listed in our pharmacy registry
  • No monthly membership, cancel anytime, free discreet shipping; HSA/FSA eligible with buy-now-pay-later plans
  • Serves patients in all 50 states via a private online consultation

The caveats

  • 'All sales are final' — no refunds once medication has left the pharmacy
  • Exact price is plan-dependent, shown after you pick a product; advertised 'starting at $269', with a lower $140 intro on oral semaglutide
  • References LegitScript but without an independently verifiable seal — we couldn't confirm certification
  • Compounded semaglutide and tirzepatide only — no brand-name (Wegovy/Zepbound) options
  • Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name

The brief

Best for: Women-focused compounded semaglutide or tirzepatide in injection, oral or ODT form with a named pharmacy. Tell Her Doc is a women-focused, self-pay telehealth program for compounded GLP-1 weight loss — compounded semaglutide and tirzepatide in injection, oral, and orally-dissolving-tablet forms, plus microdoses.

Ranked #225 of 546 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Before you decide

The questions readers ask next after reading about Tell Her Doc.

Closest here

The providers scoring nearest Tell Her Doc — the realistic shortlist if you're weighing it.

Weighing Tell Her Doc against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs Tell Her Doc, and every provider that outranks it is listed on the Tell Her Doc alternatives ranking.

More providers we track (24)

515 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect Tell Her Doc's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Tell Her Doc's site. Not medical advice; see our disclosure.

← Back to all rankings